Literature DB >> 20674970

FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis.

Andrea Zieris1, Silvana Prokoph, Kandice R Levental, Petra B Welzel, Milauscha Grimmer, Uwe Freudenberg, Carsten Werner.   

Abstract

Tissue engineering therapies require biomaterials capable of encouraging an angiogenic response. To dissect the influence of different pro-angiogenic stimuli a set of starPEG-heparin hydrogels with varied physicochemical properties was used as a highly efficient reservoir and tunable delivery system for basic fibroblast growth factor (FGF-2) and vascular endothelial growth factor (VEGF). The engineered gel materials could be precisely tailored by decoupling the biomolecular functionalization from the variation of the viscoelastic matrix characteristics. Culture experiments with human umbilical vein endothelial cells (HUVECs) revealed the interplay of growth factor presentation, adhesive characteristics and elasticity of the gel matrices in triggering differential cellular behavior which allowed identifying effective pro-angiogenic conditions. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674970     DOI: 10.1016/j.biomaterials.2010.07.021

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  45 in total

Review 1.  Decoupling polymer properties to elucidate mechanisms governing cell behavior.

Authors:  Xintong Wang; Timothy C Boire; Christine Bronikowski; Angela L Zachman; Spencer W Crowder; Hak-Joon Sung
Journal:  Tissue Eng Part B Rev       Date:  2012-06-05       Impact factor: 6.389

Review 2.  Incorporation of heparin into biomaterials.

Authors:  Shelly E Sakiyama-Elbert
Journal:  Acta Biomater       Date:  2013-09-08       Impact factor: 8.947

3.  Molecular weight and concentration of heparin in hyaluronic acid-based matrices modulates growth factor retention kinetics and stem cell fate.

Authors:  Amit K Jha; Anurag Mathur; Felicia L Svedlund; Jianqin Ye; Yerem Yeghiazarians; Kevin E Healy
Journal:  J Control Release       Date:  2015-04-27       Impact factor: 9.776

Review 4.  Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review.

Authors:  Marwa Tallawi; Elisabetta Rosellini; Niccoletta Barbani; Maria Grazia Cascone; Ranjana Rai; Guillaume Saint-Pierre; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2015-07-06       Impact factor: 4.118

Review 5.  Growth factor-eluting technologies for bone tissue engineering.

Authors:  Ethan Nyberg; Christina Holmes; Timothy Witham; Warren L Grayson
Journal:  Drug Deliv Transl Res       Date:  2016-04       Impact factor: 4.617

Review 6.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

7.  Modular GAG-matrices to promote mammary epithelial morphogenesis in vitro.

Authors:  Mirko Nowak; Uwe Freudenberg; Mikhail V Tsurkan; Carsten Werner; Kandice R Levental
Journal:  Biomaterials       Date:  2016-10-06       Impact factor: 12.479

Review 8.  Biomaterials for Bioprinting Microvasculature.

Authors:  Ryan W Barrs; Jia Jia; Sophia E Silver; Michael Yost; Ying Mei
Journal:  Chem Rev       Date:  2020-09-01       Impact factor: 60.622

Review 9.  Glycosaminoglycan-Based Biohybrid Hydrogels: A Sweet and Smart Choice for Multifunctional Biomaterials.

Authors:  Uwe Freudenberg; Yingkai Liang; Kristi L Kiick; Carsten Werner
Journal:  Adv Mater       Date:  2016-07-27       Impact factor: 30.849

10.  In Situ Crosslinkable Gelatin Hydrogels for Vasculogenic Induction and Delivery of Mesenchymal Stem Cells.

Authors:  Sue Hyun Lee; Yunki Lee; Young Wook Chun; Spencer W Crowder; Pampee P Young; Ki Dong Park; Hak-Joon Sung
Journal:  Adv Funct Mater       Date:  2014-11-19       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.